Brief Description of the Company
Founded in 2015, Tobio Novelfarma is a fast growing, dynamic, innovative pharmaceutical company focused on developing innovative medicines to satisfy the unmet needs of patients both in domestic and international markets. Tobio Novelfarma has a wide product portfolio offering treatment options in genetic and rare diseases, oncology, dermatology, paediatric diseases and gastro intestinal system diseases. Tobio Novelfarma has a strong a R&D team targeted to develop innovative products with the capability of developing high number of projects. Tobio Novelfarma maintains sustainability by continuous investment in R&D projects. Its success results from combining an entrepreneurial spirit, operational excellence and a strong ambition for continued growth. Tobio Novelfarma supports excessive innovation collaborating with prominent universities, public research institutions, and partner companies. By investing in R&D, Tobio Novelfarma targets to develop high quality, safe & effective, easy to use, affordable products. Tobio Novelfarma believes establishing long term relations with its partner companies offering them different business models including finished product supply, co-development opportunities and licensing out of its Products.

Production Area
Currently working with contract manufacturer companies for the production of its products. Tobio Novelfarma plans to inaugurate its manufacturing facility within 2 years.

GMP Certificates
Working with third party manufacturing facilities having Turkish GMP and GMP certificates of different authorities.

Number of Employees
60